<DOC>
	<DOCNO>NCT02994745</DOCNO>
	<brief_summary>The purpose study evaluate Pharmacokinetics Safety / Tolerability Fimasartan Atorvastatin Healthy Male volunteer .</brief_summary>
	<brief_title>A Clinical Trial Evaluate Pharmacokinetics Safety/Tolerability Fimasartan Atorvastatin Healthy Male Volunteers .</brief_title>
	<detailed_description>This randomize , open-label , single dose , 3x3 partial replicate crossover study evaluate pharmacokinetics safety/tolerability . Within period , randomized subject 2 dose regimen fix dose combination Fimasartan/Atorvastatin co-administration Fimasartan Atorvastatin .</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>A Healthy male age 1950 year Body weight 55kg BMI 18 ~ 27 ( kg/m2 ) . A subject provide write informed consent voluntarily confirm willingness participate study , inform full detail study comply protocol . A subject eligible accord investigator 's assessment History presence clinically significant medical psychiatric condition disease . History gastrointestinal disease resection Hypersensitivity ingredient investigational product ( IP ) medication , food . Genetic Problem Galactose intolerance , Lapp lactase deficiency Glucosegalactose malabsorption . A subject take drug inhibit induce significantly DrugMetabolizing Enzyme within 1months . Positive result serum examination ( HIV , B C viral test , Syphilis ) . Seated BP le 100/65 mmHg great 140/90 mmHg screening . Participation study within 3months . History whole blood donation within 2months Apheresis 2 week .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>